Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.85 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10447924 | 1.00 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL473236 | 1.00 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL7785857 | 1.00 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL13387616 | 1.00 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL13387437 | 1.00 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL8435881 | 0.98 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL10816622 | 0.98 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL13506577 | 0.98 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL3897800 | 0.98 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL11050872 | 0.98 | ACHE (0.81) | ACHEEPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968168-B2 | Isocyanate production method | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-04-16 | — | — | US | disclosed |
| US-9404132-B2 | Method for producing 1,5-pentamethylenediamine, 1,5-pentamethylenediamine, 1,5-pentamethylene diisocyanate, method for producing 1,5-pentamethylene diisocyanate, polyisocyanate composition, and polyurethane resin | MITSUI CHEMICALS, INC. (JP) | 2016-08-02 | — | — | US | disclosed |
| EP-2412703-B1 | URETHANE COMPOUND AND PROCESS FOR PRODUCTION THEREOF, AND ISOCYANATE AND PROCESS FOR PRODUCTION THEREOF | MITSUI CHEMICALS INC (JP) | 2016-06-29 | — | — | EP | disclosed |
| US-9150502-B2 | Urethane compound and method for producing the same, and isocyanate and method for producing the same | MITSUI CHEMICALS, INC. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20130079486-A1 | METHOD FOR PRODUCING 1,5-PENTAMETHYLENEDIAMINE, 1,5-PENTAMETHYLENEDIAMINE, 1,5-PENTAMETHYLENE DIISOCYANATE, METHOD FOR PRODUCING 1,5-PENTAMETHYLENE DIISOCYANATE, POLYISOCYANATE COMPOSITION, AND POLYURETHANE RESIN | MITSUI CHEMICALS, INC. (JP) | 2013-03-28 | — | — | US | disclosed |
| EP-2412703-A1 | URETHANE COMPOUND AND PROCESS FOR PRODUCTION THEREOF, AND ISOCYANATE AND PROCESS FOR PRODUCTION THEREOF | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20120010427-A1 | URETHANE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ISOCYANATE AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | IDH3A, ALKBH3, CPS1 | ACHE 29/4885EPHX1 3020/4885EPHX2 1193/4885 |
| US-10968168-B2 | Isocyanate production method | IDH3A, ALKBH3, CPS1 | ACHE 29/4885EPHX1 3020/4885EPHX2 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.